These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7703923)

  • 1. Interlocking triads of growth control in tumors.
    Michelson S; Leith JT
    Bull Math Biol; 1995 Mar; 57(2):345-66. PubMed ID: 7703923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A theoretical explanation of "concomitant resistance".
    Michelson S; Leith JT
    Bull Math Biol; 1995 Sep; 57(5):733-47. PubMed ID: 7606223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of partial hepatectomy on the growth characteristics and hypoxic fractions of xenografted DLD-2 human colon cancers.
    Leith JT; Padfield G; Michelson S
    Radiat Res; 1992 Nov; 132(2):263-8. PubMed ID: 1438710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control.
    Michelson S; Leith JT
    J Theor Biol; 1994 Aug; 169(4):327-38. PubMed ID: 7967626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration.
    Gutman M; Singh RK; Price JE; Fan D; Fidler IJ
    Invasion Metastasis; 1994-1995; 14(1-6):362-71. PubMed ID: 7657529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors and growth control of heterogeneous cell populations.
    Michelson S; Leith JT
    Bull Math Biol; 1993 Sep; 55(5):993-1011. PubMed ID: 8374530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice.
    Heinrich S; Jochum W; Graf R; Clavien PA
    J Hepatol; 2006 Jul; 45(1):35-42. PubMed ID: 16698111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of administration of basic fibroblast growth factor on hypoxic fractions in xenografted DLD-2 human tumours: time dependence.
    Leith JT; Michelson S
    Br J Cancer; 1993 Oct; 68(4):727-31. PubMed ID: 8398700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.
    Leith JT; Papa G; Quaranto L; Michelson S
    Br J Cancer; 1992 Aug; 66(2):345-8. PubMed ID: 1503909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis as a strategy for tumor growth control.
    Herblin WF; Gross JL
    Mol Chem Neuropathol; 1994; 21(2-3):329-36. PubMed ID: 7522007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.
    Hara Y; Ogata Y; Shirouzu K
    J Exp Clin Cancer Res; 2000 Dec; 19(4):497-504. PubMed ID: 11277329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth, morphology, and function of xenotransplanted human tumors.
    Shimosato Y; Kameya T; Hirohashi S
    Pathol Annu; 1979; 14 Pt 2():215-57. PubMed ID: 94941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human tumor xenografts transplanted under the renal capsule of conventional mice. Growth rates and host immune response.
    Aamdal S; Fodstad O; Pihl A
    Int J Cancer; 1984 Nov; 34(5):725-30. PubMed ID: 6500747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
    Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation.
    Kubota T
    J Cell Biochem; 1994 Sep; 56(1):4-8. PubMed ID: 7806591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.
    Shalinsky DR; Brekken J; Zou H; McDermott CD; Forsyth P; Edwards D; Margosiak S; Bender S; Truitt G; Wood A; Varki NM; Appelt K
    Ann N Y Acad Sci; 1999 Jun; 878():236-70. PubMed ID: 10415735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
    Wu SP; Theodorescu D; Kerbel RS; Willson JK; Mulder KM; Humphrey LE; Brattain MG
    J Cell Biol; 1992 Jan; 116(1):187-96. PubMed ID: 1730743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preirradiation of transplantation site on growth characteristics and hypoxic fractions in human colon tumor xenografts.
    Leith JT; Padfield G; Quaranto L; Michelson S
    Cancer Res; 1992 Apr; 52(8):2162-6. PubMed ID: 1559219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of thermal sensitivity of xenografted human DLD-2 tumors by administration of basic fibroblast growth factor.
    Leith JT
    Radiat Res; 1994 Apr; 138(1):139-42. PubMed ID: 8146294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3.
    Bian J; Wang Y; Smith MR; Kim H; Jacobs C; Jackman J; Kung HF; Colburn NH; Sun Y
    Carcinogenesis; 1996 Sep; 17(9):1805-11. PubMed ID: 8824499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.